Gene Symbol | Gene ID | Gene Info |
---|---|---|
Rest
|
ENSMUSG00000029249.9 | RE1-silencing transcription factor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_77266952_77267103 | Rest | 831 | 0.504221 | -0.64 | 3.9e-08 | Click! |
chr5_77265130_77265281 | Rest | 286 | 0.861357 | -0.41 | 1.1e-03 | Click! |
chr5_77267608_77267759 | Rest | 1487 | 0.294224 | -0.34 | 7.6e-03 | Click! |
chr5_77267986_77268522 | Rest | 2058 | 0.220156 | -0.34 | 7.8e-03 | Click! |
chr5_77246501_77246652 | Rest | 18915 | 0.115153 | -0.26 | 4.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_4989098_4990412 | 131.56 |
Npas4 |
neuronal PAS domain protein 4 |
149 |
0.89 |
chr7_79501250_79502506 | 96.01 |
Mir9-3hg |
Mir9-3 host gene |
1757 |
0.18 |
chr19_42255346_42256673 | 94.37 |
Golga7b |
golgi autoantigen, golgin subfamily a, 7B |
270 |
0.88 |
chr6_127766683_127768449 | 92.82 |
Gm42738 |
predicted gene 42738 |
24 |
0.95 |
chr6_121472749_121474141 | 89.37 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
178 |
0.95 |
chr2_136713069_136714459 | 89.10 |
Snap25 |
synaptosomal-associated protein 25 |
286 |
0.92 |
chr8_123413418_123414506 | 82.55 |
Tubb3 |
tubulin, beta 3 class III |
2372 |
0.11 |
chr11_41999400_42000640 | 80.46 |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, subunit gamma 2 |
336 |
0.92 |
chr2_157913335_157913704 | 77.06 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
1134 |
0.51 |
chr2_181313043_181314281 | 75.01 |
Stmn3 |
stathmin-like 3 |
838 |
0.42 |
chr2_153031440_153032820 | 72.40 |
Xkr7 |
X-linked Kx blood group related 7 |
278 |
0.86 |
chr11_55607331_55608633 | 71.26 |
Glra1 |
glycine receptor, alpha 1 subunit |
161 |
0.96 |
chr6_45059266_45059508 | 70.68 |
Cntnap2 |
contactin associated protein-like 2 |
30 |
0.98 |
chr19_47016270_47016724 | 69.68 |
Nt5c2 |
5'-nucleotidase, cytosolic II |
1344 |
0.28 |
chr1_75277211_75278430 | 67.74 |
Resp18 |
regulated endocrine-specific protein 18 |
464 |
0.62 |
chr18_31446492_31447667 | 67.35 |
Syt4 |
synaptotagmin IV |
327 |
0.87 |
chr3_114904046_114905354 | 64.20 |
Olfm3 |
olfactomedin 3 |
65 |
0.98 |
chr3_89763591_89764832 | 63.05 |
Chrnb2 |
cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) |
397 |
0.76 |
chr16_23889696_23891150 | 62.05 |
Sst |
somatostatin |
535 |
0.77 |
chr1_70725543_70726581 | 62.02 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
139 |
0.98 |
chr5_116590520_116593206 | 59.71 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr10_11081408_11082323 | 58.60 |
Grm1 |
glutamate receptor, metabotropic 1 |
385 |
0.89 |
chr7_51621596_51622924 | 58.59 |
Slc17a6 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 |
39 |
0.98 |
chr10_6788358_6789268 | 58.41 |
Oprm1 |
opioid receptor, mu 1 |
4 |
0.99 |
chr2_163438209_163439457 | 58.04 |
Gdap1l1 |
ganglioside-induced differentiation-associated protein 1-like 1 |
300 |
0.84 |
chr1_159523756_159524611 | 57.90 |
Tnr |
tenascin R |
342 |
0.91 |
chr5_121009225_121009749 | 57.50 |
Rph3a |
rabphilin 3A |
51 |
0.97 |
chr17_91092075_91093120 | 57.15 |
Nrxn1 |
neurexin I |
136 |
0.95 |
chr13_56895147_56895774 | 55.75 |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
277 |
0.94 |
chr14_68125690_68125841 | 55.18 |
Nefm |
neurofilament, medium polypeptide |
919 |
0.55 |
chr8_9768980_9769453 | 52.99 |
Fam155a |
family with sequence similarity 155, member A |
888 |
0.47 |
chr11_116920303_116921024 | 52.52 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
1800 |
0.3 |
chr10_49785211_49786117 | 52.21 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
2255 |
0.25 |
chr1_154723254_154724531 | 52.07 |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
2028 |
0.48 |
chr10_29142553_29142958 | 51.93 |
Soga3 |
SOGA family member 3 |
1084 |
0.4 |
chr1_34579671_34580338 | 51.73 |
1700101I19Rik |
RIKEN cDNA 1700101I19 gene |
293 |
0.5 |
chr4_15880938_15882113 | 49.91 |
Calb1 |
calbindin 1 |
259 |
0.9 |
chr1_75263068_75263858 | 49.16 |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
444 |
0.62 |
chr17_52603559_52603710 | 49.16 |
Kcnh8 |
potassium voltage-gated channel, subfamily H (eag-related), member 8 |
925 |
0.44 |
chr18_64265796_64267074 | 47.69 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
47 |
0.97 |
chr7_101421730_101422385 | 47.52 |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
211 |
0.91 |
chr5_27841594_27842778 | 46.73 |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A |
37 |
0.97 |
chr9_108825632_108827025 | 46.48 |
Celsr3 |
cadherin, EGF LAG seven-pass G-type receptor 3 |
8 |
0.91 |
chr4_148286849_148288201 | 46.01 |
Disp3 |
dispatched RND transporter family member 3 |
440 |
0.81 |
chr8_55939901_55941088 | 45.47 |
Glra3 |
glycine receptor, alpha 3 subunit |
15 |
0.98 |
chr11_102393440_102394677 | 45.14 |
Rundc3a |
RUN domain containing 3A |
655 |
0.52 |
chr16_75446825_75447522 | 44.95 |
Gm49678 |
predicted gene, 49678 |
120 |
0.98 |
chr11_118906575_118907024 | 44.46 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
1206 |
0.48 |
chr2_28914529_28916444 | 44.26 |
Barhl1 |
BarH like homeobox 1 |
19 |
0.98 |
chr1_74857238_74857656 | 44.13 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
2513 |
0.16 |
chr7_44592789_44594513 | 43.22 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chrX_7638310_7639997 | 42.87 |
Syp |
synaptophysin |
152 |
0.88 |
chr2_28195057_28195226 | 42.02 |
Olfm1 |
olfactomedin 1 |
2048 |
0.37 |
chr7_27653599_27654745 | 41.69 |
Ttc9b |
tetratricopeptide repeat domain 9B |
257 |
0.83 |
chr11_4948719_4949803 | 41.40 |
Nefh |
neurofilament, heavy polypeptide |
1197 |
0.38 |
chr6_8948312_8949000 | 41.14 |
Nxph1 |
neurexophilin 1 |
42 |
0.99 |
chr13_23990753_23991296 | 40.62 |
Scgn |
secretagogin, EF-hand calcium binding protein |
190 |
0.91 |
chr14_49524944_49526079 | 40.56 |
Slc35f4 |
solute carrier family 35, member F4 |
342 |
0.88 |
chr18_35212708_35213458 | 39.99 |
Ctnna1 |
catenin (cadherin associated protein), alpha 1 |
1847 |
0.28 |
chr5_37241461_37244349 | 39.98 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr16_94995704_94996004 | 38.92 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
1398 |
0.55 |
chr4_101549898_101551379 | 38.84 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
44 |
0.98 |
chr2_164967685_164969910 | 38.51 |
Slc12a5 |
solute carrier family 12, member 5 |
516 |
0.7 |
chr2_24762057_24762224 | 38.22 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
907 |
0.57 |
chr6_91839691_91840026 | 38.12 |
Grip2 |
glutamate receptor interacting protein 2 |
12608 |
0.15 |
chr3_80800286_80803016 | 37.75 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
928 |
0.67 |
chr4_124881258_124882719 | 37.69 |
Epha10 |
Eph receptor A10 |
1089 |
0.34 |
chr9_89737292_89737594 | 37.47 |
Ankrd34c |
ankyrin repeat domain 34C |
1002 |
0.49 |
chr2_70558567_70559918 | 37.45 |
Gad1 |
glutamate decarboxylase 1 |
2800 |
0.19 |
chr11_74619178_74619540 | 36.64 |
Ccdc92b |
coiled-coil domain containing 92B |
246 |
0.91 |
chr10_116017652_116019652 | 36.33 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr12_84698036_84698702 | 36.20 |
Syndig1l |
synapse differentiation inducing 1 like |
244 |
0.91 |
chr2_180889143_180889758 | 35.27 |
Gm14342 |
predicted gene 14342 |
210 |
0.87 |
chr9_40268795_40270233 | 35.11 |
Scn3b |
sodium channel, voltage-gated, type III, beta |
81 |
0.96 |
chr3_88219745_88221157 | 35.02 |
Gm3764 |
predicted gene 3764 |
2213 |
0.13 |
chr11_3774030_3775256 | 35.01 |
Osbp2 |
oxysterol binding protein 2 |
89 |
0.96 |
chr5_137030261_137030840 | 34.90 |
Vgf |
VGF nerve growth factor inducible |
151 |
0.91 |
chr2_25318080_25319601 | 34.85 |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
255 |
0.77 |
chr13_99899939_99901204 | 34.73 |
Cartpt |
CART prepropeptide |
70 |
0.98 |
chr2_132781102_132782201 | 33.91 |
Chgb |
chromogranin B |
373 |
0.82 |
chr9_49340496_49341455 | 33.86 |
Drd2 |
dopamine receptor D2 |
348 |
0.91 |
chr4_125300582_125301201 | 33.81 |
1700041M05Rik |
RIKEN cDNA 1700041M05 gene |
72294 |
0.1 |
chr19_22138603_22139842 | 33.67 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
105 |
0.98 |
chr7_87588060_87588319 | 33.65 |
Grm5 |
glutamate receptor, metabotropic 5 |
3791 |
0.35 |
chr17_6321918_6322069 | 33.31 |
AC183097.1 |
transmembrane protein 181 (TMEM181) pseudogene |
257 |
0.85 |
chr9_57468140_57468355 | 33.02 |
Scamp5 |
secretory carrier membrane protein 5 |
187 |
0.89 |
chr11_78495749_78496114 | 32.86 |
Sarm1 |
sterile alpha and HEAT/Armadillo motif containing 1 |
1527 |
0.18 |
chr11_100758699_100760184 | 32.71 |
Kcnh4 |
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
299 |
0.8 |
chr5_120424138_120424562 | 32.55 |
Lhx5 |
LIM homeobox protein 5 |
7349 |
0.14 |
chr17_6490728_6490879 | 32.03 |
Tmem181b-ps |
transmembrane protein 181B, pseudogene |
23781 |
0.14 |
chr12_70346335_70347339 | 31.61 |
Trim9 |
tripartite motif-containing 9 |
252 |
0.78 |
chr4_152286004_152287790 | 31.29 |
Hes3 |
hes family bHLH transcription factor 3 |
1708 |
0.23 |
chr1_93272441_93272828 | 30.81 |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
1797 |
0.19 |
chr9_104569494_104569724 | 30.59 |
Cpne4 |
copine IV |
126 |
0.98 |
chr7_49910058_49911168 | 30.49 |
Slc6a5 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 5 |
156 |
0.97 |
chr8_105693426_105694998 | 30.15 |
Carmil2 |
capping protein regulator and myosin 1 linker 2 |
852 |
0.36 |
chr12_112510243_112511522 | 30.11 |
Tmem179 |
transmembrane protein 179 |
290 |
0.89 |
chr2_180104533_180104892 | 30.09 |
Hrh3 |
histamine receptor H3 |
224 |
0.88 |
chr2_181764652_181765649 | 30.06 |
Myt1 |
myelin transcription factor 1 |
1818 |
0.27 |
chr2_109675949_109676616 | 29.73 |
Gm45346 |
predicted gene 45346 |
309 |
0.56 |
chr11_81966808_81967179 | 29.55 |
Asic2 |
acid-sensing (proton-gated) ion channel 2 |
1464 |
0.37 |
chr8_70117790_70118138 | 27.69 |
Ncan |
neurocan |
2909 |
0.11 |
chr17_28575220_28576027 | 27.48 |
Lhfpl5 |
lipoma HMGIC fusion partner-like 5 |
18 |
0.95 |
chr2_79453906_79455225 | 27.40 |
Neurod1 |
neurogenic differentiation 1 |
2186 |
0.3 |
chr5_33438280_33438483 | 27.20 |
Gm43851 |
predicted gene 43851 |
917 |
0.54 |
chr7_81492845_81494023 | 27.05 |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
245 |
0.86 |
chr14_124195406_124195650 | 26.99 |
Fgf14 |
fibroblast growth factor 14 |
2626 |
0.41 |
chr6_8957282_8958738 | 26.89 |
Nxph1 |
neurexophilin 1 |
8334 |
0.32 |
chr8_84946965_84947475 | 26.85 |
Rtbdn |
retbindin |
229 |
0.79 |
chr11_79593364_79593812 | 26.73 |
Gm23293 |
predicted gene, 23293 |
1577 |
0.24 |
chr17_72602980_72604745 | 26.44 |
Alk |
anaplastic lymphoma kinase |
35 |
0.99 |
chr7_44444675_44445863 | 26.35 |
Lrrc4b |
leucine rich repeat containing 4B |
2532 |
0.11 |
chr19_6501834_6503156 | 26.19 |
Nrxn2 |
neurexin II |
4660 |
0.14 |
chr17_69968894_69969661 | 25.79 |
Dlgap1 |
DLG associated protein 1 |
31 |
0.98 |
chr7_44335441_44336039 | 25.75 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
276 |
0.76 |
chr4_155018535_155019417 | 25.58 |
Plch2 |
phospholipase C, eta 2 |
452 |
0.75 |
chr2_31641562_31642591 | 24.56 |
Gm13425 |
predicted gene 13425 |
1487 |
0.23 |
chr5_137031183_137031462 | 23.45 |
Vgf |
VGF nerve growth factor inducible |
621 |
0.54 |
chr8_22974876_22975667 | 23.09 |
Ank1 |
ankyrin 1, erythroid |
135 |
0.96 |
chr17_69438821_69440200 | 23.02 |
Akain1 |
A kinase (PRKA) anchor inhibitor 1 |
184 |
0.52 |
chr1_74857699_74859071 | 22.73 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
3451 |
0.13 |
chr2_155775388_155775969 | 22.62 |
Mmp24 |
matrix metallopeptidase 24 |
336 |
0.8 |
chr14_32597041_32598313 | 22.58 |
Prrxl1 |
paired related homeobox protein-like 1 |
1730 |
0.3 |
chr11_79503704_79504313 | 22.44 |
Omg |
oligodendrocyte myelin glycoprotein |
76 |
0.95 |
chr14_32321702_32321963 | 22.38 |
Ogdhl |
oxoglutarate dehydrogenase-like |
187 |
0.91 |
chr3_89159053_89160201 | 22.32 |
Hcn3 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 3 |
353 |
0.68 |
chr14_79769842_79771877 | 22.30 |
Pcdh8 |
protocadherin 8 |
345 |
0.74 |
chr7_126825279_126825959 | 22.23 |
Fam57b |
family with sequence similarity 57, member B |
966 |
0.25 |
chr6_39871435_39873403 | 21.91 |
Gm26833 |
predicted gene, 26833 |
448 |
0.58 |
chr2_172040251_172043672 | 21.73 |
Cbln4 |
cerebellin 4 precursor protein |
1505 |
0.35 |
chr12_86983253_86984174 | 21.70 |
Zdhhc22 |
zinc finger, DHHC-type containing 22 |
122 |
0.95 |
chr6_113193892_113195750 | 21.56 |
Lhfpl4 |
lipoma HMGIC fusion partner-like protein 4 |
563 |
0.7 |
chr13_25269167_25270348 | 21.49 |
Nrsn1 |
neurensin 1 |
213 |
0.96 |
chr13_78171118_78171836 | 21.01 |
3110006O06Rik |
RIKEN cDNA 3110006O06 gene |
153 |
0.94 |
chr1_127496925_127497076 | 20.91 |
Tmem163 |
transmembrane protein 163 |
3344 |
0.32 |
chr1_175491665_175493009 | 20.67 |
Rgs7 |
regulator of G protein signaling 7 |
53 |
0.98 |
chr2_22622024_22623019 | 20.66 |
Gad2 |
glutamic acid decarboxylase 2 |
316 |
0.85 |
chr11_78952529_78952944 | 20.61 |
Lgals9 |
lectin, galactose binding, soluble 9 |
17594 |
0.17 |
chr2_178330099_178330250 | 20.60 |
Phactr3 |
phosphatase and actin regulator 3 |
2382 |
0.34 |
chr15_76721855_76722516 | 20.48 |
Lrrc24 |
leucine rich repeat containing 24 |
12 |
0.92 |
chr3_19694083_19695219 | 20.41 |
Crh |
corticotropin releasing hormone |
745 |
0.6 |
chr7_140922103_140923430 | 20.40 |
Nlrp6 |
NLR family, pyrin domain containing 6 |
660 |
0.42 |
chr1_72536044_72537425 | 20.21 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr4_129120600_129121975 | 19.62 |
Hpca |
hippocalcin |
4 |
0.96 |
chr4_153482229_153483249 | 19.45 |
Ajap1 |
adherens junction associated protein 1 |
72 |
0.99 |
chr15_78712161_78713435 | 19.44 |
Elfn2 |
leucine rich repeat and fibronectin type III, extracellular 2 |
2019 |
0.26 |
chr2_180890379_180892235 | 19.13 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr2_66633862_66635239 | 18.88 |
Scn9a |
sodium channel, voltage-gated, type IX, alpha |
103 |
0.98 |
chr11_82434143_82435365 | 18.48 |
Tmem132e |
transmembrane protein 132E |
3503 |
0.29 |
chr1_81076832_81077122 | 18.33 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
27 |
0.99 |
chr3_103573137_103574422 | 18.01 |
Syt6 |
synaptotagmin VI |
1452 |
0.38 |
chr2_125135832_125137073 | 17.88 |
Ctxn2 |
cortexin 2 |
181 |
0.91 |
chr5_113716630_113716816 | 17.87 |
1700069L16Rik |
RIKEN cDNA 1700069L16 gene |
8026 |
0.13 |
chr9_59578129_59578870 | 17.75 |
Celf6 |
CUGBP, Elav-like family member 6 |
162 |
0.94 |
chr15_84829506_84829657 | 17.74 |
Phf21b |
PHD finger protein 21B |
25529 |
0.14 |
chr4_127173142_127173761 | 17.32 |
Dlgap3 |
DLG associated protein 3 |
571 |
0.7 |
chr13_54750846_54750997 | 17.11 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
1047 |
0.39 |
chr2_180892979_180894605 | 17.06 |
Mir124a-3 |
microRNA 124a-3 |
248 |
0.53 |
chr3_68064789_68064954 | 17.06 |
Schip1 |
schwannomin interacting protein 1 |
69 |
0.99 |
chr11_115373706_115374845 | 17.01 |
Hid1 |
HID1 domain containing |
6519 |
0.09 |
chr9_122117041_122117220 | 16.99 |
Snrk |
SNF related kinase |
136 |
0.93 |
chr1_3670464_3671619 | 16.83 |
Xkr4 |
X-linked Kx blood group related 4 |
457 |
0.8 |
chr8_106336310_106337932 | 16.33 |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral |
867 |
0.61 |
chr12_102948664_102950014 | 16.31 |
Unc79 |
unc-79 homolog |
215 |
0.92 |
chr6_113282134_113283787 | 16.19 |
Cpne9 |
copine family member IX |
595 |
0.55 |
chr9_63147192_63147467 | 15.95 |
Skor1 |
SKI family transcriptional corepressor 1 |
318 |
0.89 |
chr3_87997410_87997915 | 15.91 |
Bcan |
brevican |
193 |
0.88 |
chr11_33680154_33680885 | 15.90 |
Kcnip1 |
Kv channel-interacting protein 1 |
52 |
0.97 |
chr15_101879968_101880119 | 15.83 |
Gm44356 |
predicted gene, 44356 |
8354 |
0.09 |
chr2_25863704_25864640 | 15.80 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
204 |
0.9 |
chr11_71389623_71390092 | 15.77 |
Gm16013 |
predicted gene 16013 |
46323 |
0.14 |
chr13_42711573_42711969 | 15.51 |
Phactr1 |
phosphatase and actin regulator 1 |
2190 |
0.39 |
chr3_27370198_27370441 | 15.48 |
Ghsr |
growth hormone secretagogue receptor |
1032 |
0.59 |
chr15_31296980_31298102 | 15.19 |
Ankrd33b |
ankyrin repeat domain 33B |
10653 |
0.14 |
chr10_128668479_128668976 | 14.97 |
Ikzf4 |
IKAROS family zinc finger 4 |
631 |
0.47 |
chr2_27141741_27142940 | 14.80 |
Fam163b |
family with sequence similarity 163, member B |
151 |
0.93 |
chr12_113187770_113188187 | 14.28 |
Tmem121 |
transmembrane protein 121 |
2048 |
0.2 |
chr2_92401342_92401648 | 14.27 |
Mapk8ip1 |
mitogen-activated protein kinase 8 interacting protein 1 |
232 |
0.86 |
chr10_42574651_42575179 | 14.11 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
5430 |
0.21 |
chrX_20919797_20921410 | 13.78 |
Syn1 |
synapsin I |
315 |
0.81 |
chr5_144542746_144543269 | 13.63 |
Nptx2 |
neuronal pentraxin 2 |
2895 |
0.34 |
chr10_45483348_45483499 | 13.45 |
Lin28b |
lin-28 homolog B (C. elegans) |
2354 |
0.33 |
chr2_26207818_26208366 | 13.31 |
Lhx3 |
LIM homeobox protein 3 |
197 |
0.88 |
chr8_78437765_78438492 | 13.00 |
Pou4f2 |
POU domain, class 4, transcription factor 2 |
1483 |
0.43 |
chr1_124845543_124845910 | 12.68 |
Dpp10 |
dipeptidylpeptidase 10 |
313 |
0.93 |
chr18_25752531_25753655 | 12.51 |
Celf4 |
CUGBP, Elav-like family member 4 |
401 |
0.88 |
chr3_83129655_83129889 | 12.47 |
Gm10710 |
predicted gene 10710 |
526 |
0.73 |
chr3_94580208_94580417 | 12.40 |
Snx27 |
sorting nexin family member 27 |
2237 |
0.15 |
chr1_5022752_5023448 | 12.21 |
Rgs20 |
regulator of G-protein signaling 20 |
3561 |
0.21 |
chr16_37384339_37385543 | 12.04 |
Stxbp5l |
syntaxin binding protein 5-like |
17 |
0.98 |
chr15_89532557_89533956 | 11.98 |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
366 |
0.78 |
chr19_44692457_44693293 | 11.90 |
Gm26644 |
predicted gene, 26644 |
2400 |
0.26 |
chr12_116485738_116486857 | 11.72 |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
464 |
0.75 |
chrX_136067038_136067798 | 11.71 |
Bex2 |
brain expressed X-linked 2 |
818 |
0.52 |
chr7_27395791_27396385 | 11.65 |
Sptbn4 |
spectrin beta, non-erythrocytic 4 |
110 |
0.94 |
chr18_37687206_37687357 | 11.51 |
Pcdhga4 |
protocadherin gamma subfamily A, 4 |
397 |
0.52 |
chr18_45563646_45564226 | 11.50 |
Kcnn2 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 |
3782 |
0.26 |
chr2_143546820_143547517 | 10.95 |
Pcsk2os1 |
proprotein convertase subtilisin/kexin type 2, opposite strand 1 |
669 |
0.53 |
chr13_54371303_54372670 | 10.75 |
Cplx2 |
complexin 2 |
637 |
0.69 |
chr10_81477498_81478256 | 10.65 |
Celf5 |
CUGBP, Elav-like family member 5 |
3033 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
39.4 | 118.3 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
23.0 | 68.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
22.2 | 66.7 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
18.0 | 54.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
17.5 | 52.6 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
16.6 | 82.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
16.3 | 49.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
16.3 | 146.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
15.9 | 47.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
15.5 | 46.5 | GO:0097503 | sialylation(GO:0097503) |
12.6 | 37.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
12.1 | 36.3 | GO:0021586 | pons maturation(GO:0021586) |
11.6 | 46.5 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
11.1 | 33.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
11.0 | 33.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
11.0 | 33.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
10.9 | 43.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
10.6 | 42.5 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
9.3 | 74.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
8.2 | 32.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
6.9 | 55.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
6.6 | 26.6 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
6.3 | 18.9 | GO:1902075 | cellular response to salt(GO:1902075) |
5.7 | 85.9 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
5.6 | 152.4 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
5.3 | 21.2 | GO:0046959 | habituation(GO:0046959) |
5.1 | 25.4 | GO:0070842 | aggresome assembly(GO:0070842) |
4.8 | 33.6 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
4.5 | 31.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
4.4 | 17.5 | GO:0006538 | glutamate catabolic process(GO:0006538) |
4.3 | 21.4 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
4.1 | 24.8 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
3.8 | 49.5 | GO:0001553 | luteinization(GO:0001553) |
3.7 | 45.0 | GO:0007614 | short-term memory(GO:0007614) |
3.7 | 11.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.6 | 7.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
3.4 | 10.1 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
3.4 | 26.9 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
3.3 | 56.6 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
3.3 | 3.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
3.2 | 44.4 | GO:0043084 | penile erection(GO:0043084) |
3.1 | 12.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
3.0 | 3.0 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.9 | 11.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.8 | 22.5 | GO:0071625 | vocalization behavior(GO:0071625) |
2.7 | 93.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
2.7 | 10.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.7 | 32.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.6 | 41.7 | GO:0006828 | manganese ion transport(GO:0006828) |
2.4 | 7.3 | GO:0021558 | trochlear nerve development(GO:0021558) |
2.4 | 26.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
2.3 | 11.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
2.3 | 13.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
2.3 | 11.3 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
2.2 | 26.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
2.2 | 11.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
2.2 | 19.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
2.1 | 19.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
2.0 | 14.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.0 | 21.9 | GO:0033574 | response to testosterone(GO:0033574) |
1.9 | 1.9 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
1.9 | 9.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.9 | 15.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.8 | 22.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
1.8 | 3.6 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.8 | 9.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.7 | 29.5 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
1.7 | 12.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.7 | 6.7 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.7 | 70.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
1.6 | 4.9 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
1.6 | 1.6 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
1.6 | 61.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
1.6 | 3.1 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.5 | 10.7 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
1.4 | 23.0 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.4 | 18.0 | GO:0045760 | positive regulation of action potential(GO:0045760) |
1.4 | 44.1 | GO:0030901 | midbrain development(GO:0030901) |
1.3 | 5.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.3 | 19.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.2 | 22.3 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
1.2 | 6.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
1.2 | 6.0 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.2 | 3.5 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 3.5 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.1 | 4.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.1 | 6.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.0 | 6.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
1.0 | 4.0 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.0 | 5.0 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.0 | 32.6 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
1.0 | 3.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.0 | 48.3 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.0 | 9.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
1.0 | 43.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.9 | 3.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.9 | 22.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.9 | 8.4 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.9 | 37.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.9 | 1.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.9 | 4.5 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.9 | 2.6 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.9 | 1.7 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.8 | 19.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.8 | 2.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.8 | 3.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.8 | 1.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.8 | 13.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.8 | 0.8 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.8 | 3.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.8 | 33.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.7 | 2.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 19.7 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.7 | 2.9 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.7 | 2.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.7 | 2.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 2.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 2.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.7 | 1.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.7 | 2.0 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 2.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.7 | 1.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.7 | 4.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 2.6 | GO:2000650 | negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.7 | 2.6 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.7 | 1.3 | GO:0002434 | immune complex clearance(GO:0002434) |
0.7 | 2.0 | GO:0015747 | urate transport(GO:0015747) |
0.6 | 1.3 | GO:0061549 | noradrenergic neuron development(GO:0003358) sympathetic ganglion development(GO:0061549) |
0.6 | 8.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.6 | 0.6 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
0.6 | 1.9 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.6 | 1.2 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.6 | 2.4 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 1.8 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.6 | 3.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.6 | 1.7 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.6 | 1.7 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.6 | 19.4 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.5 | 2.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.5 | 3.8 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.5 | 2.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 1.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.5 | 0.5 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.5 | 13.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.5 | 2.0 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.5 | 12.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.5 | 7.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.5 | 2.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 2.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.5 | 3.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 1.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.5 | 1.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.5 | 25.7 | GO:0042391 | regulation of membrane potential(GO:0042391) |
0.5 | 1.4 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.5 | 20.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 0.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.5 | 2.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 3.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.8 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 3.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.4 | 0.9 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.4 | 1.7 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.4 | 5.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 0.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 1.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 0.8 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
0.4 | 3.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.4 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.4 | 1.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 4.8 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.4 | 11.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.4 | 0.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.4 | 0.4 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.4 | 2.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.4 | 2.0 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 27.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.4 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.4 | 0.8 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
0.4 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.4 | 1.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 1.9 | GO:0050942 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) |
0.4 | 36.4 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.4 | 0.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.4 | 1.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 0.7 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.4 | 32.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.4 | 10.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.4 | 0.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.4 | 1.4 | GO:0071034 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.4 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.4 | 1.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 1.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 1.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.3 | 20.0 | GO:0014065 | phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.3 | 3.0 | GO:0001964 | startle response(GO:0001964) |
0.3 | 24.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 1.3 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.3 | 1.0 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.3 | 1.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 1.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 1.6 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 1.0 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.3 | 0.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.3 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.3 | 1.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.3 | 2.2 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.3 | 1.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.6 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.3 | 0.3 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 2.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.3 | 0.9 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 1.2 | GO:0015867 | ATP transport(GO:0015867) |
0.3 | 1.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.3 | 2.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.8 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 0.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.3 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 0.8 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.3 | 0.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.6 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.6 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 1.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 15.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.3 | 0.8 | GO:0015889 | cobalamin transport(GO:0015889) |
0.3 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.3 | 0.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) telencephalon regionalization(GO:0021978) |
0.3 | 22.7 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.3 | 2.3 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.3 | 16.6 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.3 | 0.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.3 | 0.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.2 | 1.2 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 3.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 3.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.5 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.2 | 1.7 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.2 | 0.7 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.5 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 2.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 3.0 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 0.9 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.7 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.2 | 4.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.2 | 34.1 | GO:0007286 | spermatid development(GO:0007286) |
0.2 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 3.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 0.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 3.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.2 | 0.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 5.0 | GO:0008306 | associative learning(GO:0008306) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 0.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.2 | 0.9 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.2 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 2.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 0.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.2 | GO:0071870 | cellular response to catecholamine stimulus(GO:0071870) |
0.2 | 0.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.2 | 0.8 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.2 | 1.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 13.2 | GO:0006821 | chloride transport(GO:0006821) |
0.2 | 6.2 | GO:0009749 | response to glucose(GO:0009749) |
0.2 | 0.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.2 | 0.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.2 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.2 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.2 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.2 | 0.8 | GO:0042506 | tyrosine phosphorylation of Stat5 protein(GO:0042506) |
0.2 | 0.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.2 | 0.6 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.7 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.3 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 1.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.4 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.2 | 5.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.2 | 0.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.2 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.2 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 1.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.2 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 22.6 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.2 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.2 | 0.7 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.2 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.2 | 1.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 4.6 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.2 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 0.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.3 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 46.0 | GO:0001701 | in utero embryonic development(GO:0001701) |
0.2 | 7.6 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.2 | 1.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.2 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 19.2 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.2 | 1.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.8 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 1.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 1.3 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.6 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.2 | 0.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 2.8 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 1.4 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 1.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 1.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 1.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.6 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 1.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.6 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.6 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
0.1 | 0.4 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
0.1 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 0.4 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.1 | 0.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.3 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.1 | 0.1 | GO:0060931 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
0.1 | 4.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 5.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 1.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.6 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 1.7 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.9 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.1 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.9 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 1.8 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.2 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 1.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.4 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.7 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
0.1 | 0.2 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.1 | 0.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.1 | 0.2 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.1 | 0.1 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 2.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.1 | 0.2 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.2 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.6 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.1 | 1.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 0.2 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
0.1 | 9.3 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.1 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 3.1 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.1 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.2 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.8 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 0.1 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.1 | 0.9 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 47.4 | GO:0007267 | cell-cell signaling(GO:0007267) |
0.1 | 0.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.2 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 1.2 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.3 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.1 | 0.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 2.1 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.1 | 5.2 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.1 | 0.2 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0071354 | response to interleukin-6(GO:0070741) cellular response to interleukin-6(GO:0071354) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.3 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.1 | 0.2 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.1 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.3 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.3 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.4 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.7 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.1 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.4 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.1 | 1.6 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.1 | 0.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.7 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.1 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.1 | 0.3 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.1 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 3.2 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 2.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 3.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.1 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 | 1.0 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.4 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.1 | 0.2 | GO:0042220 | response to cocaine(GO:0042220) |
0.1 | 1.7 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 0.3 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.1 | 0.1 | GO:0071839 | apoptotic process in bone marrow(GO:0071839) regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.1 | 0.2 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.1 | 22.1 | GO:0006812 | cation transport(GO:0006812) |
0.1 | 1.1 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.4 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.2 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 1.2 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 0.7 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.2 | GO:0045581 | negative regulation of T cell differentiation(GO:0045581) |
0.1 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.7 | GO:0035307 | positive regulation of protein dephosphorylation(GO:0035307) |
0.1 | 0.2 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) endocardial cushion to mesenchymal transition(GO:0090500) |
0.1 | 0.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) B cell costimulation(GO:0031296) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.1 | 0.1 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 3.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.6 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.1 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.7 | GO:0006303 | non-recombinational repair(GO:0000726) double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 0.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.1 | 0.1 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.1 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.2 | GO:0000032 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.1 | 0.2 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 1.2 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.1 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.1 | 0.9 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.1 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:0090042 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
0.1 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.1 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 1.0 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
0.1 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.1 | 1.1 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.5 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 0.2 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.3 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.1 | 0.2 | GO:1900543 | negative regulation of purine nucleotide metabolic process(GO:1900543) |
0.1 | 0.6 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.7 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.1 | 0.1 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.4 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.1 | 1.0 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.1 | 0.9 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.8 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.1 | 0.1 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
0.1 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0052428 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) negative regulation by host of symbiont molecular function(GO:0052405) modulation by host of symbiont catalytic activity(GO:0052422) modification by host of symbiont molecular function(GO:0052428) |
0.1 | 0.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.1 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
0.1 | 0.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.1 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.0 | 0.5 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.0 | 0.1 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.0 | 0.3 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.0 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.0 | 0.1 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.1 | GO:0098762 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.0 | 0.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 2.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.2 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.0 | 0.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.0 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 1.4 | GO:0046632 | alpha-beta T cell differentiation(GO:0046632) |
0.0 | 0.1 | GO:0072506 | cellular phosphate ion homeostasis(GO:0030643) phosphate ion homeostasis(GO:0055062) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.5 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.6 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.0 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 1.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.0 | 0.3 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.0 | 0.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.4 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.1 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.4 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.2 | GO:0048246 | macrophage chemotaxis(GO:0048246) |
0.0 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.7 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:0002035 | regulation of blood volume by renin-angiotensin(GO:0002016) brain renin-angiotensin system(GO:0002035) |
0.0 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.0 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.0 | 0.1 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.0 | 0.1 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 1.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.2 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.0 | 0.2 | GO:0001967 | suckling behavior(GO:0001967) |
0.0 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0019230 | proprioception(GO:0019230) sensory neuron axon guidance(GO:0097374) |
0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.0 | 0.2 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.0 | GO:0060355 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0090009 | primitive streak formation(GO:0090009) |
0.0 | 0.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.0 | 0.3 | GO:0008361 | regulation of cell size(GO:0008361) |
0.0 | 0.1 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.0 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.0 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.2 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.0 | 0.0 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.0 | 0.1 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.3 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.0 | 0.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.0 | 0.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.0 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.1 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.0 | 0.0 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.1 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.0 | 0.1 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.0 | 0.0 | GO:0031281 | positive regulation of cyclase activity(GO:0031281) |
0.0 | 3.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.0 | 0.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
0.0 | 0.4 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.1 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.0 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.4 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.0 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.0 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.0 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.2 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.0 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0010039 | response to iron ion(GO:0010039) |
0.0 | 1.2 | GO:0048511 | rhythmic process(GO:0048511) |
0.0 | 0.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) cell quiescence(GO:0044838) |
0.0 | 0.0 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:1990138 | neuron projection extension(GO:1990138) |
0.0 | 0.0 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.1 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.0 | GO:0072497 | mesenchymal stem cell differentiation(GO:0072497) regulation of mesenchymal stem cell differentiation(GO:2000739) |
0.0 | 0.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.0 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 0.1 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.0 | 0.1 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.0 | 0.7 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.0 | 0.4 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.0 | 0.2 | GO:0098792 | xenophagy(GO:0098792) |
0.0 | 0.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.0 | 0.0 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.2 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.3 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.0 | GO:0007135 | meiosis II(GO:0007135) meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.0 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.1 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.3 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.7 | GO:0050954 | sensory perception of mechanical stimulus(GO:0050954) |
0.0 | 0.0 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.0 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.0 | 0.0 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.0 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
0.0 | 0.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.0 | 0.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.0 | 0.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0048017 | inositol lipid-mediated signaling(GO:0048017) |
0.0 | 0.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.0 | 0.1 | GO:0009268 | response to pH(GO:0009268) |
0.0 | 0.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0003416 | endochondral bone growth(GO:0003416) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.0 | GO:0099558 | motor learning(GO:0061743) maintenance of synapse structure(GO:0099558) |
0.0 | 0.2 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.0 | GO:0051342 | protein maturation by protein folding(GO:0022417) regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.0 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.0 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.0 | 0.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.0 | 0.0 | GO:0043485 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 0.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 0.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.0 | 0.6 | GO:0034220 | ion transmembrane transport(GO:0034220) |
0.0 | 0.1 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 1.0 | GO:0000423 | macromitophagy(GO:0000423) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.0 | 0.0 | GO:0043486 | histone exchange(GO:0043486) |
0.0 | 0.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.2 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.0 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.0 | 0.1 | GO:0009409 | response to cold(GO:0009409) |
0.0 | 0.1 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.0 | 0.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.0 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.1 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
0.0 | 0.0 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.0 | 0.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0010934 | macrophage cytokine production(GO:0010934) |
0.0 | 0.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0006415 | translational termination(GO:0006415) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.2 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.0 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.0 | GO:0032799 | low-density lipoprotein receptor particle metabolic process(GO:0032799) |
0.0 | 0.0 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.3 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.0 | 0.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.0 | 0.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.1 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.0 | 0.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.0 | 0.0 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
0.0 | 0.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.0 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
0.0 | 0.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.0 | GO:0009211 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.0 | 0.0 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.0 | 0.0 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.0 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.0 | 0.0 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.0 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.0 | 0.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
0.0 | 0.1 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.0 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.0 | 0.0 | GO:0003207 | cardiac chamber formation(GO:0003207) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.3 | 89.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
18.2 | 54.5 | GO:0072534 | perineuronal net(GO:0072534) |
17.3 | 52.0 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
13.3 | 252.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
7.8 | 46.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
7.5 | 15.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
7.4 | 44.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
7.0 | 126.1 | GO:0030673 | axolemma(GO:0030673) |
6.9 | 62.3 | GO:0005883 | neurofilament(GO:0005883) |
5.9 | 190.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
5.4 | 64.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
5.1 | 143.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
4.9 | 58.3 | GO:0031045 | dense core granule(GO:0031045) |
4.8 | 87.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
4.3 | 52.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
3.3 | 33.0 | GO:0044292 | dendrite terminus(GO:0044292) |
3.3 | 19.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
3.1 | 9.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.0 | 48.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
2.9 | 23.3 | GO:1904115 | axon cytoplasm(GO:1904115) |
2.8 | 110.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.8 | 11.1 | GO:0008091 | spectrin(GO:0008091) |
2.6 | 50.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
2.3 | 34.9 | GO:0097440 | apical dendrite(GO:0097440) |
2.2 | 26.7 | GO:0032426 | stereocilium tip(GO:0032426) |
1.9 | 11.2 | GO:0005915 | zonula adherens(GO:0005915) |
1.7 | 52.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.7 | 10.0 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.6 | 62.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.4 | 57.4 | GO:0034707 | chloride channel complex(GO:0034707) |
1.4 | 7.1 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.4 | 37.9 | GO:0031941 | filamentous actin(GO:0031941) |
1.3 | 114.2 | GO:0043204 | perikaryon(GO:0043204) |
1.2 | 3.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.2 | 21.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.0 | 45.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.0 | 1.0 | GO:0097513 | myosin II filament(GO:0097513) |
1.0 | 90.0 | GO:0043679 | axon terminus(GO:0043679) |
0.9 | 12.3 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.9 | 42.4 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.8 | 9.1 | GO:0061702 | inflammasome complex(GO:0061702) |
0.8 | 2.4 | GO:0035061 | interchromatin granule(GO:0035061) |
0.8 | 1.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.8 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.7 | 34.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.7 | 2.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 2.0 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.6 | 11.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.6 | 61.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 1.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.6 | 1.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 2.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.5 | 5.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.5 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 3.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 2.8 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.8 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 150.9 | GO:0045202 | synapse(GO:0045202) |
0.4 | 4.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.4 | 144.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 0.8 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 1.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.4 | 2.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.4 | 25.7 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 68.6 | GO:0030141 | secretory granule(GO:0030141) |
0.4 | 1.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.4 | 38.4 | GO:0030424 | axon(GO:0030424) |
0.4 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 4.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 49.6 | GO:0043005 | neuron projection(GO:0043005) |
0.3 | 1.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 1.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 1.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.3 | 3.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 36.9 | GO:0043025 | neuronal cell body(GO:0043025) |
0.3 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 1.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 1.7 | GO:0070187 | telosome(GO:0070187) |
0.2 | 1.9 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.2 | 26.4 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 0.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 3.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 2.3 | GO:0099503 | secretory vesicle(GO:0099503) |
0.2 | 0.9 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 0.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 0.8 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 4.6 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 172.3 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.2 | 0.8 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 2.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.2 | 0.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.2 | 0.9 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 2.2 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.2 | 1.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.2 | 7.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 2.3 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 2.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.2 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.2 | 0.5 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.2 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 4.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.7 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.8 | GO:0044297 | cell body(GO:0044297) |
0.1 | 0.3 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 107.3 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 9.1 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 4.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 1.5 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 7.3 | GO:0097458 | neuron part(GO:0097458) |
0.1 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 59.9 | GO:0005886 | plasma membrane(GO:0005886) |
0.1 | 1.4 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 24.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 44.6 | GO:0030054 | cell junction(GO:0030054) |
0.1 | 2.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.1 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 0.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 2.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.4 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.9 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 1.1 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 21.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.1 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 0.1 | GO:0005594 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
0.1 | 1.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 265.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 4.0 | GO:0072372 | primary cilium(GO:0072372) |
0.1 | 3.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.1 | 0.8 | GO:0097346 | Ino80 complex(GO:0031011) INO80-type complex(GO:0097346) |
0.1 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 7.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 159.4 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 0.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.2 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 212.2 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 1.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 15.4 | GO:0016020 | membrane(GO:0016020) |
0.0 | 0.2 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 0.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 0.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.0 | 0.2 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 0.0 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.3 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.0 | 0.2 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.3 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.0 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.0 | GO:0031417 | NatC complex(GO:0031417) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
19.1 | 114.9 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
17.0 | 51.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
11.8 | 59.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
11.0 | 33.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
11.0 | 44.0 | GO:0030911 | TPR domain binding(GO:0030911) |
10.2 | 30.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
9.2 | 46.2 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
8.5 | 42.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
8.3 | 24.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
7.9 | 63.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
7.9 | 31.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
7.5 | 45.1 | GO:0005499 | vitamin D binding(GO:0005499) |
7.0 | 56.4 | GO:0008430 | selenium binding(GO:0008430) |
6.7 | 33.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
6.7 | 26.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
6.3 | 126.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
5.4 | 21.8 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
5.4 | 27.0 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
5.4 | 16.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
5.0 | 19.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
4.8 | 57.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
4.7 | 23.4 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
4.5 | 27.1 | GO:0016595 | glutamate binding(GO:0016595) |
4.4 | 83.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
4.4 | 47.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.3 | 21.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
4.0 | 52.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
3.9 | 85.8 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
3.7 | 51.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
3.6 | 47.1 | GO:0015643 | toxic substance binding(GO:0015643) |
3.3 | 94.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
3.2 | 45.0 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
3.2 | 48.2 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
3.2 | 38.1 | GO:0031005 | filamin binding(GO:0031005) |
3.0 | 9.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
3.0 | 44.7 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
2.6 | 23.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.2 | 12.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.0 | 22.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
2.0 | 53.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
2.0 | 13.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.9 | 5.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.9 | 34.9 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.7 | 47.0 | GO:0030507 | spectrin binding(GO:0030507) |
1.7 | 5.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.6 | 13.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.5 | 19.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.5 | 48.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.5 | 4.5 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
1.4 | 11.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
1.4 | 11.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.3 | 13.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.3 | 19.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.2 | 11.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.2 | 8.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.1 | 31.5 | GO:0045296 | cadherin binding(GO:0045296) |
1.1 | 33.7 | GO:0015485 | cholesterol binding(GO:0015485) |
1.0 | 3.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.0 | 27.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
1.0 | 30.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 4.8 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.9 | 39.5 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.9 | 21.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.9 | 3.6 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.9 | 13.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.8 | 1.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.8 | 9.8 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.8 | 73.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.8 | 23.4 | GO:0005267 | potassium channel activity(GO:0005267) |
0.8 | 19.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.8 | 3.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.7 | 188.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.7 | 78.8 | GO:0002020 | protease binding(GO:0002020) |
0.7 | 2.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.7 | 2.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.7 | 1.4 | GO:0002046 | opsin binding(GO:0002046) |
0.7 | 2.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 2.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.6 | 2.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.6 | 1.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 104.1 | GO:0003729 | mRNA binding(GO:0003729) |
0.6 | 1.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 0.6 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.6 | 2.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.6 | 1.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.6 | 49.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.6 | 48.6 | GO:0005179 | hormone activity(GO:0005179) |
0.6 | 6.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 3.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.5 | 2.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 26.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.5 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.5 | 11.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.5 | 1.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 16.3 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.5 | 7.9 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.5 | 1.8 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.4 | 12.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.4 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 5.5 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.4 | 0.8 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.4 | 2.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.4 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 1.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.4 | 1.6 | GO:0009374 | biotin binding(GO:0009374) |
0.4 | 34.0 | GO:0005261 | cation channel activity(GO:0005261) |
0.4 | 4.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 5.3 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 1.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 7.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.4 | 1.4 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.3 | 3.8 | GO:0030506 | ankyrin binding(GO:0030506) |
0.3 | 1.4 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.3 | 8.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 7.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.3 | 2.0 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 1.0 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 1.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.3 | 1.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 10.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.3 | 1.9 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 3.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 17.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 2.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.3 | 1.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 0.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.3 | 1.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.3 | 1.2 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.3 | 1.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 1.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 0.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.3 | 0.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.8 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 2.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 6.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.3 | 0.8 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 113.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.2 | 2.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 0.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.2 | 0.7 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 3.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 0.2 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 2.9 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.2 | 2.9 | GO:0005343 | organic acid:sodium symporter activity(GO:0005343) |
0.2 | 0.4 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 5.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 2.5 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 1.6 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 3.2 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 1.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 4.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.2 | 0.4 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 2.7 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.2 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 5.1 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 1.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.3 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 2.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 4.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 1.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 12.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.2 | 0.9 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 0.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 7.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.1 | 2.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.5 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.1 | 1.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.8 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.4 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 0.3 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
0.1 | 2.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 3.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 24.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.1 | 4.2 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 16.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 0.4 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 2.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 4.9 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 1.4 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.8 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 3.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 3.0 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.2 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 3.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.3 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.6 | GO:0052630 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.1 | 0.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 2.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.4 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.6 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.4 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 0.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 5.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.1 | 9.8 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 2.1 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 5.6 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.1 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 0.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 0.3 | GO:0008933 | lytic transglycosylase activity(GO:0008933) |
0.1 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 2.7 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.1 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 0.6 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 2.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 2.2 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.1 | 0.5 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 25.1 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 4.9 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 2.4 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.6 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 3.9 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.1 | 0.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 12.7 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 1.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 0.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.1 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 6.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 2.0 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.2 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.1 | 0.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.1 | 0.2 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.2 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 1.4 | GO:0010296 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.7 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 1.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.0 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.6 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.4 | GO:0034841 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.0 | 0.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.0 | 0.5 | GO:0043748 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.8 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.3 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 2.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.6 | GO:0000907 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.6 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.0 | 0.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.6 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 2.1 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.3 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 2.0 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 4.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.0 | 2.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 3.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.3 | GO:0034871 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.0 | 0.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.2 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 1.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
0.0 | 0.1 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0016247 | channel regulator activity(GO:0016247) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 22.7 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 94.5 | GO:0005515 | protein binding(GO:0005515) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.0 | GO:0043176 | amine binding(GO:0043176) |
0.0 | 0.1 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.0 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.0 | 0.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.0 | 0.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.0 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.2 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 1.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.2 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.1 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.1 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 57.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 10.1 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.6 | 15.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 34.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.6 | 10.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 19.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 15.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 9.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 66.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 5.2 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 9.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.4 | 36.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 4.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 12.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.3 | 75.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 0.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 3.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.2 | 2.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.2 | 3.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.7 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.4 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 2.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 2.7 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.5 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 1.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 1.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.6 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 2.1 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 1.8 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 7.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 1.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 1.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.5 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 6.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 0.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.8 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.0 | 0.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.0 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.5 | 189.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
8.4 | 92.8 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
6.5 | 52.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
4.4 | 48.2 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
4.1 | 45.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
3.7 | 55.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
3.7 | 51.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
3.3 | 46.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
3.2 | 67.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.9 | 20.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.7 | 37.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.5 | 59.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
2.5 | 19.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
2.4 | 33.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
2.3 | 43.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
2.2 | 22.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
2.2 | 59.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
2.1 | 6.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
1.9 | 78.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.7 | 33.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.5 | 17.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.4 | 17.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.4 | 57.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.8 | 19.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 3.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 11.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.7 | 28.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.7 | 16.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.7 | 7.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.6 | 6.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 14.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 8.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.5 | 69.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 23.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.4 | 4.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.4 | 0.4 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.4 | 10.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.3 | 1.7 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 19.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 3.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 18.7 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 11.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.2 | 3.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.4 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 2.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 0.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.2 | 1.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 6.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 0.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 1.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.8 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 1.5 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 1.4 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 21.3 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 1.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.9 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.1 | 0.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 0.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.6 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 5.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 2.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 1.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.9 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 2.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 2.9 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.8 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.6 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 0.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 0.3 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 0.9 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 0.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.6 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 0.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 4.7 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 1.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 0.3 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.7 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 0.4 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.7 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 1.8 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.6 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.3 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 1.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.1 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 0.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.1 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.1 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.0 | 0.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |